The Journal of Organic Chemistry
Article
Compound 13. Compound 12 (230 mg, 0.156 mmol) and
triphenylphosphine (73.7 mg, 0.281 mmol) were dissolved in MeOH
(2 mL). The reaction mixture was heated to reflux for overnight. The
solvent was removed by rotary evaporation. The residue was purified
by column chromatography over silica gel with 15:1 CH2Cl2 /CH3OH
and then with 6:1:0.1 CH2Cl2/CH3OH/Et3N (6/1/0.1) as the eluents
associate with water instead of the nonpolar solvent. The
different self-assembled structures (i.e., water-filled nanopores
vs spherical, water-filled reverse micelles) simply result from the
different topologies of the amphiphiles.
The effectiveness of the NDI group in lipid membranes is
noteworthy. The aromatic donor−acceptor interactions
between an NDI and a 1,5-dialkoxynaphthalene derivative
were found to be 1−2 orders of magnitude stronger than the
acceptor−acceptor interactions in several polar solvents.31 Our
leakage data, however, clearly shows that the acceptor−acceptor
interactions were more effective at promoting the stacking of
the oligocholate macrocycles. Our current explanation for the
result was based on the solvation of the NDI group in nonpolar
environments. In our experience, compounds with the NDI
group tend to have much poorer solubility than pyrene
derivatives in common organic solvents including hydro-
carbons. The poor solubility probably comes from the strong
intermolecular interactions of the NDI groups and its poor
solvation by common organic solvents. When the NDI-
functionalized oligocholates enter the lipid membrane, the
poor solubility of the NDI group in hydrocarbons translates to
a stronger tendency to aggregate in lipid hydrocarbon and was
clearly beneficial to the transport ability of macrocycle 8.
1
to afford an off-white powder (103 mg, 46%). H NMR (400 MHz,
CD3OD/CDCl3 = 1:1, δ): 7.28 (br, 5H), 5.04 (br, 2H), 4.25(br,1H),
3.93 (br, 3H), 3.78 (br, 3H) 3.62 (s, 3H), 3.49 (br, 2H), 3.13(m, 2H),
2.38−1.0 (a series of m), 0.88(s, 9H), 0.64 (d, 9H). 13C NMR (100
MHz, CDCl3/CD3OD = 1:1, δ): 175.6, 175.2, 174.5, 171.8, 157.6,
136.9, 128.5, 128.0, 127.8, 73.0, 68.1, 66.6, 61.6, 53.2, 50.7, 48.8, 46.5,
42.8, 41.8, 39.5, 36.3, 35.4, 35.0, 33.6, 32.8, 31.8, 31.1, 29.9, 28.4, 27.7,
26.6, 23.3, 22.5, 18.2, 17.0, 12.6. ESI-HRMS (m/z): [M + H]+ calcd
for C86H138N5O13 1449.0286, found 1449.0273.
Compound 14. Hydrolyzed compound 13 (50 mg, 0.034 mmol),
BOP (75 mg, 0.169 mmol), and HOBT (23 mg, 0.169 mmol) were
dissolved in DMF (30 mL), and DIPEA (60 μL, 0.34 mmol) was
added. The mixture was allowed to react in a microwave reactor at 100
°C for 1 h and poured into dilute HCl aqueous solution (0.05 M, 50
mL). The precipitate formed was collected by suction filtration,
washed with water, dried in air, and purified by column
chromatography over silica gel with 10:1 CH2Cl2/CH3OH as the
1
eluent to afford an ivory powder (47 mg, 98%). H NMR (300 MHz,
CD3OD, δ): 7.30 (br, 5H), 5.04 (br, 2H), 4.14 (br,1H), 3.92 (br, 3H),
3.78 (br, 3H), 3.48 (br, 2H), 3.13 (m, 3H), 2.38−1.0 (a series of m),
0.88(s, 9H), 0.67 (d, 9H). 13C NMR (100 MHz, CDCl3/CD3OD =
1:1, δ): 176.7, 175.2, 174.9, 172.3, 158.2, 136.9, 128.5, 128.0, 127.8,
73.0, 68.1, 66.6, 61.6, 53.2, 50.7, 48.8, 46.5, 42.8, 41.8, 39.5, 36.3, 35.4,
35.0, 33.6, 32.8, 31.8, 31.1, 29.9, 28.4, 27.7, 26.6, 23.3, 22.2, 19.1, 16.8,
EXPERIMENTAL SECTION
■
The syntheses of compound 3,14a 6,14a 9,32 10,21 11,19c 12,14a 16,14a
17,32 and 1832 were previously reported. The preparation of LUVs,32
the procedures for the leakage assays,32 and the incorporation of
oligocholates into liposomes by detergent dialysis and direct addition
to preformed LUVs14a were reported previously.
+
12.8. ESI-HRMS (m/z): [M + Na] calcd for C85H133N5O12Na
1438.9843, found 1438.9833.
Compound 15. Pd/C (240 mg, 10 wt %) was added to a solution
of 5 (236 mg, 0.167 mmol) in CH3OH (20 mL). The mixture was
stirred under a H2 balloon at room temperature for 3 d. Pd/C was
removed by filtration through a pad of Celite, and the solvent was
removed by rotary evaporation to afford a white power (150 mg,
80%). 1H NMR (300 MHz, CD3OD, δ): 4.23 (br,1H), 3.93 (br, 3H),
3.78 (br, 3H), 3.47 (br, 3H), 2.74−0.98 (a series of m), 0.89 (s, 9H),
0.67 (d, 9H). 13C NMR (100 MHz, CDCl3/CD3OD = 1:1, δ): 176.8,
175.4, 175.1, 172.6, 158.5, 136.9, 73.0, 68.1, 66.6, 53.2, 50.7, 48.8, 46.5,
42.8, 41.8, 39.5, 36.3, 35.4, 35.0, 33.6, 32.8, 31.8, 31.1, 29.9, 28.4, 27.7,
General Methods. For spectroscopic purposes, methanol,
hexanes, and ethyl acetate were of HPLC grade. All other reagents
and solvents were of ACS-certified grade or higher and were used as
received from commercial suppliers.
Compound 4. The amine derivative14a of compound 6 (50 mg,
0.037 mmol), compound 17 (56 mg, 0.108 mmol), and
diisopropylethylamine (DIPEA, 32 μL, 0.184 mmol) were dissolved
in anhydrous DMF (0.2 mL). The mixture was stirred at 50 °C
overnight and poured into dilute HCl aqueous solution (0.05 M, 50
mL). The precipitate was collected by suction filtration and purified by
preparative TLC using 9:1 CHCl3/CH3OH as the developing solvent
+
26.6, 23.3, 22.2, 19.3, 16.6, 12.4. ESI-HRMS (m/z): [M + H] calcd
for C77H128N5O10 1282.9656, found 1282.9645.
1
Compound 7. Compound 15 (80 mg, 0.062 mmol), compound
16 (72 mg, 0.187 mmol), and DIPEA (109 μL, 0.624 mmol) were
dissolved in anhydrous DMF (0.2 mL). The mixture was stirred at 60
°C overnight and poured into a dilute HCl aqueous solution (0.05 M,
30 mL). The precipitate was collected by suction filtration and purified
by preparative TLC using 9:1 CHCl3/CH3OH as the developing
to afford a light brown powder (36 mg, 50%). H NMR (400 MHz,
CDCl3/CD3OD = 1:1, δ): 8.68 (s, 4H), 7.75 (m, 1H), 7.43 (m, 1H),
4.30 (m, 3H), 4.14 (br, 5H), 3.86 (br, 3H), 3.72 (br, 2H), 3.39 (m,
2H), 3.08 (br, 2H), 2.70 (q, 1H), 2.38−1.0 (a series of m), 0.61 (s,
1H). 13C NMR (100 MHz, CDCl3/CD3OD = 1:1, δ): 175.3, 174.9,
174.5, 171.9, 164.5, 144.5, 131.0, 127.3, 125.9, 125.1, 125.0, 124.9,
124.8, 124.7, 123.3, 120.7, 72.9, 68.0, 61.5, 53.5, 49.6, 46.4, 45.7, 42.2,
39.5, 36.7, 35.7, 34.6,32.7, 31.8, 29.6,27.5, 27.1, 26.6, 25.9, 23.1, 22.3,
17.0, 12.2. ESI-HRMS (m/z): [M + Na]+ calcd for C102H148N10NaO15
1776.1018, found 1776.1008.
1
solvent to afford an off-white powder (40 mg, 42%). H NMR (400
MHz, CDCl3/CD3OD = 1:1, δ): 8.30 (m, 2H), 8.09 (m, 4H), 7.98 (m,
2H), 7.84 (m, 1H), 4.21(m, 1H), 3.90 (br, 3H), 3.77 (br, 3H), 3.59 (q,
2H), 3.50 (br, 3H), 2.92 (m, 2H), 2.46 (br, 2H), 2.38−1.0 (a series of
m), 0.58 (m, 7 H), 0.44 (s, 2H). 13C NMR (100 MHz, CDCl3/
CD3OD = 1:1, δ): 175.3, 174.9, 174.5, 171.9,144.5, 136.0, 127.3,
125.9, 125.1,125.0,124.9,124.8, 124.7, 123.3, 120.7, 72.9, 68.0, 61.5,
53.5, 49.6, 46.4, 45.7, 42.2, 39.5, 36.7, 35.7, 34.6,32.7, 31.8, 29.6,27.5,
27.1, 26.6, 25.9, 23.1, 22.3, 17.0, 12.2. ESI-HRMS (m/z): [M + H]+
calcd for C97H142N5O11 1553.0700, found 1553.0687.
Compound 5. The amine derivative14a of compound 6 (92 mg,
0.067 mmol), compound 16 (58 mg, 0.169 mmol), and DIPEA (59
μL, 0.337 mmol) were dissolved in anhydrous DMF (0.3 mL). The
mixture was allowed to react in a microwave reactor at 100 °C for 30
min and poured into dilute HCl aqueous solution (0.05 M, 50 mL).
The precipitate was collected by suction filtration and purified by
preparative TLC using 9:1 CHCl3/CH3OH as the developing solvent
Compound 8. Compound 15 (55 mg, 0.043 mmol), compound
17 (65 mg, 0.129 mmol), and DIPEA (37 μL, 0.215 mmol) were
dissolved in anhydrous DMF (0.2 mL). The mixture was stirred at 60
°C overnight and poured into a dilute HCl aqueous solution (0.05 M,
30 mL). The precipitate was collected by suction filtration and purified
by preparative TLC using 9:1 CHCl3/CH3OH as the developing
1
to afford an off-white powder (50 mg, 45%). H NMR (400 MHz,
CDCl3/CD3OD = 1:1, δ): 8.60 (br, 1H), 8.42 (br, 1H), 8.26−7.99
(9H), 4.48 (br, 3H), 4.35 (br, 1H), 3.92 (br, 3H), 3.76 (br, 3H), 3.58
(br, 3H), 3.51 (br, 1H), 2.85 (br, 1H), 2.38−1.0 (a series of m), 0.88
(s, 9H), 0.67 (d, 9H). 13C NMR (100 MHz, CDCl3/CD3OD = 1:1,
δ): 175.2, 174.8, 173.7, 171.7, 162.8, 144.7, 130.5, 126.8,120.8, 73.1,
67.9, 61.6, 56.7, 53.3, 46.5, 39.7, 34.7, 31.9, 29.4, 26.5, 23.3, 20.4, 16.7,
13.4, 11.9. ESI-HRMS (m/z): [M + H]+ calcd for C97H139N8O11
1592.0558, found 1592.0570.
1
solvent to afford an off-white powder (52 mg, 72%). H NMR (400
MHz, CDCl3/CD3OD = 1:1, δ): 8.73 (s, 4H), 4.24(m, 4H), 3.94 (br,
3H), 3.79 (br, 3H), 3.52 (q, 2H), 3.17 (br, 3H), 2.45−0.73 (a series of
m), 0.66 (m, 9 H). 13C NMR (100 MHz, CDCl3/CD3OD = 1:1, δ):
4686
dx.doi.org/10.1021/jo3004056 | J. Org. Chem. 2012, 77, 4679−4687